SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000904454-15-000786
Filing Date
2015-12-18
Accepted
2015-12-18 14:31:20
Documents
1
Period of Report
2015-01-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 2981
  Complete submission text file 0000904454-15-000786.txt   4541
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Issuer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12481 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130
Business Address
Shah Nimesh (Reporting) CIK: 0001660394 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36332 | Film No.: 151296440